Ovid Therapeutics
OVID
OVID
42 hedge funds and large institutions have $61.5M invested in Ovid Therapeutics in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
-3
Holders Change %
-6.67%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
12
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$534K |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$403K |
| 3 |
State Street
Boston,
Massachusetts
|
+$191K |
| 4 |
Jennison Associates
New York
|
+$153K |
| 5 |
CI
Cowen Inc
New York
|
+$88K |
Top Sellers
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$3.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.42M |
| 3 |
Goldman Sachs
New York
|
-$923K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$503K |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$328K |
